Ignite Creation Date:
2025-12-24 @ 11:41 PM
Ignite Modification Date:
2026-02-11 @ 10:31 PM
Study NCT ID:
NCT01556451
Status:
COMPLETED
Last Update Posted:
2017-04-12
First Post:
2012-02-17
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
ZOSTAVAX™ Safety and Immunogenicity in Korean Adults (V211-034)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-04
Start Date Type:
None
Primary Completion Date:
2012-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-10
Completion Date Type:
ACTUAL
First Submit Date:
2012-02-17
First Submit QC Date:
None
Study First Post Date:
2012-03-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-07-19
Results First Submit QC Date:
None
Results First Post Date:
2013-09-23
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-03-14
Last Update Post Date:
2017-04-12
Last Update Post Date Type:
ACTUAL